LVT logo

Levitee Labs Stock Price

Symbol: CNSX:LVTMarket Cap: CA$538.4kCategory: Pharmaceuticals & Biotech

LVT Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

LVT Community Narratives

There are no narratives available yet.

Recent LVT News & Updates

No updates

Levitee Labs Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$0

Other Expenses

CA$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
Earnings per share (EPS)
0
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
0%

Levitee Labs Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About LVT

Founded
2019
Employees
n/a
CEO
David Bentil
WebsiteView website
www.leviteelabs.com

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.

Canadian Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.1%
  • 1 Year: 21.0%
  • Year to Date: 9.9%
Over the last 7 days, the market has remained flat, although notably the Materials sector gained 6.6% in that time. More promisingly, the market is up 21% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading